Physician profile
Shane R Smith
NPI 1538134572
$3,256.26
in general payments reported to CMS, 2019-2025
18 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $262 · 2021: $284 · 2022: $419 · 2023: $1,222 · 2024: $544 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Travel and Lodging: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.02 |
| Travel and Lodging | $685.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $920.96 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $433.82 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $402.74 | 2019-2025 | Dupixent |
| Genzyme Corporation | $356.31 | 2020-2025 | |
| Intersect Ent, INC. | $282.67 | 2019-2021 | |
| Medtronic, INC. | $194.29 | 2024 | Stealthstation S8 Platform, Propel, Signia |
| Organogenesis INC. | $128.29 | 2021-2023 | Puraply |
| Stryker Corporation | $94.46 | 2019-2023 | Claw II |
| Optinose US, INC. | $83.08 | 2019-2022 | |
| Aerin Medical INC. | $83.00 | 2022-2024 | |
| Allergan, INC. | $70.62 | 2020 | |
| Acclarent, INC | $63.22 | 2019 | |
| Smith+Nephew, INC. | $46.46 | 2022 | |
| Hikma Pharmaceuticals USA | $33.33 | 2023 | Ryaltris |
| Medtronic USA, INC. | $20.11 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.06 | 2025 | Tezspire |
| Arbor Pharmaceuticals, INC. | $13.44 | 2019 | |
| Olympus America INC. | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.